On April 29, 2015, DiagnoCure Inc. announced that Yves Fradet, Louise Proulx, Andrew Sheldon, Jacques Simoneau, and Vincent R. Zurawski, were re-elected by shareholders at the 2013 annual and special meeting of shareholders held on April 29, 2015. In addition, the Company stated that shareholders approved and ratified the new by-laws of the Company - including the advanced notice by-law, and approved all unallocated options under Company's stock option plan.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 43 | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.17% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- DGCRF Stock
- News 9342-8530 Québec Inc.
- Declaration of Voting Results by DiagnoCure